Title
Category
Credits
Event date
Cost
Evaluation and Treatment of Primary Central Nervous System Lymphoma
  • CNS Cancers
  • 0.50 AAPA Category 1 CME credit
  • 0.50 ACPE contact hours
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC contact hours
  • 0.50 Participation
$0.00
Neuroradiologic evaluation, an important part of diagnosis and evaluation of the effectiveness of subsequent therapy, can be confounded by steroids administration used to alleviate symptoms of primary central nervous system lymphomas (PCNSL). These confounding, non-diagnostic results can delay therapies for PCNSL, which commonly consist of methotrexate-based induction and consolidation treatments. Even with therapy, more than half the cases will relapse or be refractory to therapy.